Matthias Linder, David Grundmann, Caroline Kellner, Till Demal, Lara Waldschmidt, Oliver Bhadra, Sebastian Ludwig, Lisa Voigtländer, Ina von der Heide, Nicole Nebel, Laura Hannen, Johannes Schirmer, Hermann Reichenspurner, Stefan Blankenberg, Lenard Conradi, Niklas Schofer, Andreas Schäfer, Moritz Seiffert
(1) Background: Transfemoral transcatheter aortic valve implantation (TAVI) has become the standard treatment for most patients with severe symptomatic aortic stenosis. Intravascular lithotripsy may facilitate transfemoral TAVI (IVL-TAVI) even in patients with severely calcified iliofemoral disease. We assessed technical aspects and clinical outcomes of this novel approach compared to alternative transaxillary access (TAX-TAVI). (2) Methods: IVL-TAVI was performed for severe iliofemoral calcifications precluding standard transfemoral access in 30 patients from 2019 to 2022 at a single academic heart center...
March 4, 2024: Journal of Clinical Medicine